MIM NEWS                            FOR IMMEDIATE RELEASE


For further information please contact:            Richard H. Friedman
                                                   Chief Executive Officer
                                                   MIM Corporation
                                                   914-460-1635




                MIM CORPORATION ACQUIRES SPECIALTY INFUSION HOME
                      HEALTHCARE COMPANY AMERICAN DISEASE
                          MANAGEMENT ASSOCIATES, L.L.C.
              -- Strengthens MIM's Push Into Specialty Pharmacy --

ELMSFORD, New York, August 4, 2000 - MIM Corporation (NASDAQ: MIMS), an
independent pharmacy benefit management, specialty pharmaceutical and
fulfillment/e-commerce organization, announced today that it has completed the
acquisition of all of the equity interests of American Disease Management
Associates, L.L.C., or "ADIMA", an integrated specialty pharmacy and home
healthcare provider of infusion and injectible specialty pharmaceutical products
and services. MIM Corporation acquired ADIMA for approximately $24 million, $19
million in cash and the balance in MIM Corporation common stock.

ADIMA, located in Livingston, New Jersey, provides high-tech intravenous and
injectible specialty pharmaceutical products to chronically ill patients
receiving healthcare services from home by highly trained IV certified
registered nurses, typically after a hospital discharge. ADIMA has established
itself among its managed care client base as a high quality provider of
specialty pharmaceutical infusion and injectible products. ADIMA provides these
products and services to managed care organization's plan members principally
residing in the New York and New Jersey metropolitan areas.

The transaction will be accounted for as a purchase and is anticipated to be
accretive to MIM's 2000 earnings. MIM financed the acquisition partially with
its available cash on hand and utilized a portion of its $30 million revolving
credit facility with General Electric Capital Corporation for the balance. The
Company previously disclosed that it had secured, through its principal
operating subsidiary, MIM Health Plans, Inc., a $30 million revolving credit
facility, to be used by the Company for, among other things, acquisitions.

"The acquisition of ADIMA further solidifies the strong foundation that MIM has
built over the last several months in contracting with new managed care
organizations and our existing PBM managed care and TPA clients to deliver
specialty pharmaceutical products





and services to their members who are afflicted with chronic illnesses and other
serious conditions and are required to receive costly, hard to administer oral,
injectible or infusion pharmaceutical products." said Richard H. Friedman,
Chairman and Chief Executive Officer of MIM. "We are excited to have the entire
current ADIMA management team joining us to manage and grow this exciting new
business area that focuses on the delivery and administering of specialty
pharmaceutical infusion and injectible products and services.

ADIMA and MIM anticipate opening similar facilities in MIM's existing Ohio,
Rhode Island and Tennessee facilities to provide these highly technical products
and services to plan members in those markets. ADIMA's managed care clients and
their members will benefit greatly from this arrangement; they will continue to
receive the same quality products and services they have come to expect from
ADIMA over the years. They will also receive the added value provided by MIM's
expertise in delivering highly sophisticated clinical pharmacy and technology
programs and services to its clients and their plan members," Mr. Friedman
added.

MIM Corporation is an independent pharmacy benefit management, specialty
pharmaceutical and fulfillment/ e-commerce organization that partners with
healthcare providers and sponsors to control prescription drug costs. MIM's
innovative pharmacy benefit products and services use clinically sound
guidelines to ensure cost control and quality care. MIM's specialty
pharmaceutical division specializes in serving the chronically ill affected by
life threatening diseases. MIM's fulfillment and e-commerce pharmacy specializes
in serving individuals that require long-term maintenance medications. MIM's
online pharmacy, http://www.mimrx.com/, develops private label websites to offer
groups innovative, customized, health information services and products on the
Internet for their members.

This press release may contain statements which constitute forward looking
statements within the meaning of the Private Securities Litigation Reform Act of
1995, including statements regarding the intent, belief or current expectations
of the Company and its subsidiaries (including its newly acquired subsidiary
American Disease Management Associates, L.L.C.) and their respective directors,
officers and other members of management with respect to, among other things,
predictions of future operating performance of the Company and management's
plans and objectives. Investors are cautioned that any such forward looking
statements are not guarantees of future performance and involve risks and
uncertainties, and that actual results may differ materially from those forward
looking statements as a result of various factors. Factors that could cause or
contribute to such differences include, but are not limited to those described
in the Company's periodic filings with the Securities and Exchange Commission,
including the Company's Form 10-K for the year ended December 31, 1999 and its
Form 10-Q for the period ended March 31, 2000.

                                     # # # #